Development of a dual channel detection system for pan-genotypic simultaneous quantification of hepatitis B and delta viruses

References

• Liu Y, Maya S, Ploss A. Animal models of hepatitis B virus infection-success, challenges, and future directions. Viruses. 2021;13:777. doi:10.3390/v13050777
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu H, Hu Z, et al. Hepatitis B virus virions produced under nucleos(t)ide analogue treatment are mainly not infectious because of irreversible DNA chain termination. Hepatology. 2020;71:463–476. doi:10.1002/hep.30844
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address, [email protected], European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398. doi:10.1016/j.jhep.2017.03.021
   PubMed Web of Science ®Google Scholar
• Terrault NA, Bzowej NH, Chang K, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261–283. doi:10.1002/hep.28156
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1–98. doi:10.1007/s12072-015-9675-4
   PubMed Web of Science ®Google Scholar
• Taylor JM. Hepatitis delta virus. Virology. 2006;344:71–76. doi:10.1016/j.virol.2005.09.033
   PubMed Web of Science ®Google Scholar
• Koh C, Heller T, Glenn JS. Pathogenesis of and new therapies for hepatitis D. Gastroenterology. 2019;156:461–476.e1. doi:10.1053/j.gastro.2018.09.058
   PubMed Web of Science ®Google Scholar
• Lempp FA, Ni Y, Urban S. Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options. Nat Rev Gastroenterol Hepatol. 2016;13:580–589. doi:10.1038/nrgastro.2016.126
   PubMed Web of Science ®Google Scholar
• Chen HY, Shen D-T, Ji D-Z, et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut. 2019;68:512–521. doi:10.1136/gutjnl-2018-316601
   PubMed Web of Science ®Google Scholar
• Miao Z, Zhang S, Ou X, et al. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020;221:1677–1687. doi:10.1093/infdis/jiz633
   PubMed Web of Science ®Google Scholar
• Negro F, Lok AS. Hepatitis D: a review. JAMA. 2023;330:2376. doi:10.1001/jama.2023.23242
   PubMed Web of Science ®Google Scholar
• Wedemeyer H, Yurdaydìn C, Dalekos GN, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med. 2011;364:322–331. doi:10.1056/NEJMoa0912696
   PubMed Web of Science ®Google Scholar
• Wedemeyer H, Yurdaydin C, Hardtke S, et al. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial. Lancet Infect Dis. 2019;19:275–286. doi:10.1016/S1473-3099(18)30663-7
   PubMed Web of Science ®Google Scholar
• Urban S, Neumann-Haefelin C, Lampertico P. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut. 2021;70:1782–1794. doi:10.1136/gutjnl-2020-323888
   PubMed Web of Science ®Google Scholar
• Kuo MY, Chao M, Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol. 1989;63:1945–1950. doi:10.1128/JVI.63.5.1945-1950.1989
   PubMed Web of Science ®Google Scholar
• Wei L, Ploss A. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation. Nat Microbiol. 2020;5:715–726. doi:10.1038/s41564-020-0678-0
   PubMed Web of Science ®Google Scholar
• Liu Y, Cafiero TR, Park D, et al. Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells. Nat Commun. 2023;14:3582. doi:10.1038/s41467-023-39148-3
   PubMed Web of Science ®Google Scholar
• de Jong YP, Dorner M, Mommersteeg MC, et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med. 2014;6:254ra129. doi:10.1126/scitranslmed.3009512
   PubMed Web of Science ®Google Scholar
• Liu Y, Park D, Cafiero TR, et al. Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses. JHEP Rep. 2022;4:100535. doi:10.1016/j.jhepr.2022.100535
   PubMedGoogle Scholar
• Winer BY, Huang T, Low BE, et al. Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection. Virology. 2017;502:63–72. doi:10.1016/j.virol.2016.12.017
   PubMed Web of Science ®Google Scholar
• Wang J, Shen T, Huang X, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J Hepatol. 2016;65:700–710. doi:10.1016/j.jhep.2016.05.029
   PubMed Web of Science ®Google Scholar
• Yan Z, Zeng J, Yu Y, et al. HBVcircle: a novel tool to investigate hepatitis B virus covalently closed circular DNA. J Hepatol. 2017;66:1149–1157. doi:10.1016/j.jhep.2017.02.004
   PubMed Web of Science ®Google Scholar
• Deny P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol. 2006;307:151–171. doi:10.1007/3-540-29802-9_8
   PubMed Web of Science ®Google Scholar
• Shen S, Liu W, Zeng G, et al. Conditional replication and secretion of hepatitis B virus genome uncover the truncated 3’ terminus of encapsidated viral pregenomic RNA. J Virol. 2023;97:e0076023. doi:10.1128/jvi.00760-23
   PubMedGoogle Scholar
• Shen S, Xie Z, Cai D, et al. Biogenesis and molecular characteristics of serum hepatitis B virus RNA. PLoS Pathog. 2020;16:e1008945. doi:10.1371/journal.ppat.1008945
   PubMed Web of Science ®Google Scholar
• Wang W, Lempp FA, Schlund F, et al. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates. J Hepatol. 2021;75:311–323. doi:10.1016/j.jhep.2021.03.025
   PubMed Web of Science ®Google Scholar
• Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;3:e00049. doi:10.7554/eLife.00049
   Google Scholar
• Ni Y, Lempp FA, Mehrle S, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014;146:1070–1083. doi:10.1053/j.gastro.2013.12.024
   PubMed Web of Science ®Google Scholar
• Madejon A, Cotonat T, Bartolome J, et al. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response. Hepatology. 1994;19:1331–1336. doi:10.1002/hep.1840190602
   PubMed Web of Science ®Google Scholar
• Lempp FA, Schlund F, Rieble L, et al. Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation. Nat Commun. 2019;10:2265. doi:10.1038/s41467-019-10211-2
   PubMed Web of Science ®Google Scholar
• Ferns RB, Nastouli E, Garson JA. Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard. J Virol Methods. 2012;179:189–194. doi:10.1016/j.jviromet.2011.11.001
   PubMed Web of Science ®Google Scholar
• Wang Y, Glenn JS, Winters MA, et al. A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection. Diagn Microbiol Infect Dis. 2018;92:112–117. doi:10.1016/j.diagmicrobio.2018.05.016
   PubMed Web of Science ®Google Scholar
• Mederacke I, Bremer B, Heidrich B, et al. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol. 2010;48:2022–2029. doi:10.1128/JCM.00084-10
   PubMed Web of Science ®Google Scholar
• Tian Y, Fan Z, Zhang X, et al. CRISPR/Cas13a-assisted accurate and portable hepatitis D virus RNA detection. Emerg Microbes Infect. 2023;12:2276337. doi:10.1080/22221751.2023.2276337
   PubMed Web of Science ®Google Scholar
• Chudy, M, Hanschmann K-M, Bozdayi M, et al. Collaborative study to establish a World Health Organization international standard for hepatitis D virus RNA for nucleic acid amplification technique (NAT)-based assays. No. WHO/BS/2013.2227. World Health Organization; 2013. Available from: https://iris.who.int/handle/10665/96341
   Google Scholar
• Liu Y, Zeng W, Xi J, et al. Over-gap PCR amplification to identify presence of replication-competent HBV DNA from integrated HBV DNA: an updated occult HBV infection definition. J Hepatol. 2019;70:557–559. doi:10.1016/j.jhep.2018.10.003
   PubMed Web of Science ®Google Scholar